Published 02-03-20
Issued by Novartis
For the seventh consecutive year, Novartis is publishing an annual Novartis in Society ESG report. The report has been prepared in accordance with the GRI Standards: Core option. It supplements the “Build trust with society” section in the 2019 Novartis Annual Review and the 2019 Novartis Annual Report.
February 3, 2020 - For the seventh consecutive year, Novartis is publishing an annual Novartis in Society ESG report. The report has been prepared in accordance with the GRI Standards: Core option. It supplements the “Build trust with society” section in the 2019 Novartis Annual Review and the 2019 Novartis Annual Report.
The report is divided into four chapters based on our corporate responsibility (CR) material clusters and the global health and CR strategic priorities: holding ourselves to the highest ethical standards; being part of the solution on pricing and access; addressing global health challenges; and being a responsible citizen. In each chapter, readers will find more focused and contextual information about the priority topics arising from our CR materiality assessment.
2019 HIGHLIGHTS
Access
Global health
Ethics and compliance
Responsible citizenship
Download the 2019 Novartis in Society ESG Report
For more information on our corporate responsibility activities, visit our website.
Novartis Media Relations
Central media line: +41 61 324 2200
E-mail: media.relations@novartis.com
Twitter: https://twitter.com/novartis
LinkedIn: https://www.linkedin.com/
Facebook: https://www.facebook.com/
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.